ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease

Clinical trial NCT01336088 · COMPLETED

Trial details

NCT number: NCT01336088
Sponsor: Addex Pharma S.A.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2011-04-01
Primary completion: 2012-02-01
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.